| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 131010* | 2009 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 112566 | 2009 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 112424 | 2009 |
| Statistical methods for assessing agreement between two methods of clinical measurements JM Blaud, DG Altman Lancet 12, 307-310, 1986 | 52334 | 1986 |
| Statistical methods for assessing agreement between two methods of clinical measurement JM Bland, DG Altman The lancet 327 (8476), 307-310, 1986 | 52253 | 1986 |
| Cochrane handbook for systematic reviews of interventions JPT Higgins, J Thomas, J Chandler, M Cumpston, T Li, MJ Page, ... John Wiley & Sons, 2019 | 49483 | 2019 |
| Measuring inconsistency in meta-analyses JPT Higgins, SG Thompson, JJ Deeks, DG Altman Bmj 327 (7414), 557-560, 2003 | 43867 | 2003 |
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ... Journal of clinical epidemiology 62 (10), e1-e34, 2009 | 38644 | 2009 |
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... Bulletin of the World Health Organization 85, 867-872, 2007 | 30065* | 2007 |
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... Bulletin of the World Health Organization 85, 867-872, 2007 | 28522* | 2007 |
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... Bulletin of the World Health Organization 85, 867-872, 2007 | 28467* | 2007 |
| Practical statistics for medical research DG Altman CRC press, 1990 | 24002 | 1990 |
| The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials JPT Higgins, DG Altman, PC Gøtzsche, P Jüni, D Moher, AD Oxman, ... Bmj 343, 2011 | 20521 | 2011 |
| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 13066 | 2017 |
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials D Moher, KF Schulz, D Altman, Consort Group, CONSORT Group Jama 285 (15), 1987-1991, 2001 | 9341 | 2001 |
| Measuring agreement in method comparison studies JM Bland, DG Altman Statistical methods in medical research 8 (2), 135-160, 1999 | 8815 | 1999 |
| QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies PF Whiting, AWS Rutjes, ME Westwood, S Mallett, JJ Deeks, JB Reitsma, ... Annals of internal medicine 155 (8), 529-536, 2011 | 8462 | 2011 |
| Assessing risk of bias in included studies JPT Higgins, DG Altman John Wiley and sons, 2008 | 7441 | 2008 |
| Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials KF Schulz, I Chalmers, RJ Hayes, DG Altman Jama 273 (5), 408-412, 1995 | 7411 | 1995 |
| Statistics notes: Cronbach's alpha JM Bland, DG Altman Bmj 314 (7080), 572, 1997 | 7039* | 1997 |
